CASE PRESENTATION
Dr. Gayatri Sahu
 The patient is 62 years male.
 USG showed stone in urinary bladder ,
with no obvious growth.
 Prostatic chips had been sent for
histopathology.
DIAGNOSIS ????
The 2016 WHO Classification of
tumors of Urothelial tract .
Papillary Urothelial
Carcinoma
Macroscopic Appearances:
 Some are barely visible small papillary
excrescences whereas others are huge
masses of confluent papillary tissue that
may have a “cauliflower-like” appearance
almost filling the bladder lumen.
 They are typically soft, delicate, and friable.
Microscopic findings
 Complex branching pattern
 The papillae are usually covered by
more than seven layers of cells.
 Cytologic atypia present.
 Atypical mitosis may b present
 Papillary carcinomas are graded by
using cytologic and architectural criteria,
and this has major prognostic
significance.
 A system of three categories is widely
recommended and generally used.
 PAPILLARY UROTHELIAL NEOPLASM OF LOW
MALIGNANT POTENTIAL
 LOW-GRADE PAPILLARY CARCINOMA
 HIGH-GRADE PAPILLARY CARCINOMA
PAPILLARY UROTHELIAL
NEOPLASM OF LOW MALIGNANT
POTENTIAL
 Papillae usually covered by a thickened
epithelium.
 The cells are normally oriented and
show mild degrees of nuclear
enlargement and hyperchromasia.
 Mitoses are infrequent and basally
located if present.
 Apoptotic bodies rarely seen.
 Invasion is infrequent.
LOW-GRADE PAPILLARY
CARCINOMA
 Branching papillae, fused and delicate.
 Predominantly ordered, yet minimal
crowding and minimal loss of polarity;
any thickness; cohesive.
 Enlarged round to oval nucleus with
variation in size and shape.
 Mitosis - occasional, at any level.
HIGH-GRADE PAPILLARY
CARCINOMA
 Papillae are fused, branching.
 Predominantly disordered with frequent
loss of polarity; any thickness; often
discohesive.
 Nucleus - enlarged , hyperchromatic
with moderate–marked pleomorphism.
 Multiple prominent nucleoli .
 Mitosis- Usually frequent, at any level with
abnormal mitotic forms.
Local spread and metastases
 Assessment of invasion in cases of papillary
carcinoma may be difficult.
 Tangential sectioning of the bases of papillae
may simulate invasion by giving the
appearance of detached nests of cells in the
lamina propria.
 Most crucial to prognosis is the presence or
absence of invasion of the muscularis propria.
 Invasive bladder carcinomas (especially
high-grade tumors) are associated with
zones of atypical proliferation,
carcinoma in situ, and early invasive
carcinomas in areas remote from the
main tumor mass.
 Bladder carcinoma may extend into the
neck of the bladder, urethra, prostatic
ducts, and seminal vesicle;
more commonly than to the ureters.
 Lymph node metastases in the pelvic
chains are found in 25% of the invasive
tumors.
 Distant metastases seen in lungs, liver,
bone, and central nervous system.
To differentiate between high-grade
malignant tumor for which the differential
diagnosis is between urothelial and
prostatic carcinoma:
 CK34ßE12, CK7, P53 = positive in
urothelial carcinoma.
 PSA, PSAP, and Leu7(CD57) = positive in
prostatic carcinoma.
 This panel of six markers is essential to
differentiate.
The selection of the antibody panel to use
in a given case depends to a large extent
on the differential diagnosis being
considered
1.Urothelial carcinoma with inverted
growth pattern versus inverted
papilloma:
 Ki-67,
 P53 and
 CK20
(all of them usually positive in the former)
2. High-grade urothelial carcinoma versus
poorly differentiated prostatic
adenocarcinoma:
 CK34ßE12 and p63 (positive in the
former), and
 PSA (positive in the latter)
3. Metastatic micropapillary urothelial
carcinoma of prostate versus
micropapillary carcinoma of other sites:
 uroplakin,
 CK20,
 TTF-1, and
 hormone receptors
 The pathology report of a bladder biopsy that
contains a tumor should include the following
information:
1 Grade
2 Configuration (papillary or solid)
3 Depth of penetration
4 Presence of muscle
5 Lymphatic invasion
6 Blood vessel invasion
7 Changes in adjacent mucosa if present
Thank you

CASE PRESENTATION UB.......................pptx

  • 1.
  • 2.
     The patientis 62 years male.  USG showed stone in urinary bladder , with no obvious growth.
  • 3.
     Prostatic chipshad been sent for histopathology.
  • 11.
  • 12.
    The 2016 WHOClassification of tumors of Urothelial tract .
  • 15.
    Papillary Urothelial Carcinoma Macroscopic Appearances: Some are barely visible small papillary excrescences whereas others are huge masses of confluent papillary tissue that may have a “cauliflower-like” appearance almost filling the bladder lumen.  They are typically soft, delicate, and friable.
  • 16.
    Microscopic findings  Complexbranching pattern  The papillae are usually covered by more than seven layers of cells.  Cytologic atypia present.  Atypical mitosis may b present
  • 17.
     Papillary carcinomasare graded by using cytologic and architectural criteria, and this has major prognostic significance.  A system of three categories is widely recommended and generally used.
  • 18.
     PAPILLARY UROTHELIALNEOPLASM OF LOW MALIGNANT POTENTIAL  LOW-GRADE PAPILLARY CARCINOMA  HIGH-GRADE PAPILLARY CARCINOMA
  • 19.
    PAPILLARY UROTHELIAL NEOPLASM OFLOW MALIGNANT POTENTIAL  Papillae usually covered by a thickened epithelium.  The cells are normally oriented and show mild degrees of nuclear enlargement and hyperchromasia.  Mitoses are infrequent and basally located if present.  Apoptotic bodies rarely seen.  Invasion is infrequent.
  • 20.
    LOW-GRADE PAPILLARY CARCINOMA  Branchingpapillae, fused and delicate.  Predominantly ordered, yet minimal crowding and minimal loss of polarity; any thickness; cohesive.  Enlarged round to oval nucleus with variation in size and shape.  Mitosis - occasional, at any level.
  • 21.
    HIGH-GRADE PAPILLARY CARCINOMA  Papillaeare fused, branching.  Predominantly disordered with frequent loss of polarity; any thickness; often discohesive.  Nucleus - enlarged , hyperchromatic with moderate–marked pleomorphism.  Multiple prominent nucleoli .  Mitosis- Usually frequent, at any level with abnormal mitotic forms.
  • 23.
    Local spread andmetastases  Assessment of invasion in cases of papillary carcinoma may be difficult.  Tangential sectioning of the bases of papillae may simulate invasion by giving the appearance of detached nests of cells in the lamina propria.  Most crucial to prognosis is the presence or absence of invasion of the muscularis propria.
  • 24.
     Invasive bladdercarcinomas (especially high-grade tumors) are associated with zones of atypical proliferation, carcinoma in situ, and early invasive carcinomas in areas remote from the main tumor mass.
  • 25.
     Bladder carcinomamay extend into the neck of the bladder, urethra, prostatic ducts, and seminal vesicle; more commonly than to the ureters.  Lymph node metastases in the pelvic chains are found in 25% of the invasive tumors.  Distant metastases seen in lungs, liver, bone, and central nervous system.
  • 26.
    To differentiate betweenhigh-grade malignant tumor for which the differential diagnosis is between urothelial and prostatic carcinoma:  CK34ßE12, CK7, P53 = positive in urothelial carcinoma.  PSA, PSAP, and Leu7(CD57) = positive in prostatic carcinoma.  This panel of six markers is essential to differentiate.
  • 27.
    The selection ofthe antibody panel to use in a given case depends to a large extent on the differential diagnosis being considered 1.Urothelial carcinoma with inverted growth pattern versus inverted papilloma:  Ki-67,  P53 and  CK20 (all of them usually positive in the former)
  • 28.
    2. High-grade urothelialcarcinoma versus poorly differentiated prostatic adenocarcinoma:  CK34ßE12 and p63 (positive in the former), and  PSA (positive in the latter)
  • 29.
    3. Metastatic micropapillaryurothelial carcinoma of prostate versus micropapillary carcinoma of other sites:  uroplakin,  CK20,  TTF-1, and  hormone receptors
  • 30.
     The pathologyreport of a bladder biopsy that contains a tumor should include the following information: 1 Grade 2 Configuration (papillary or solid) 3 Depth of penetration 4 Presence of muscle 5 Lymphatic invasion 6 Blood vessel invasion 7 Changes in adjacent mucosa if present
  • 31.